SCHEMBL23558496

SCHEMBL23558496

COc1cnccc1-c1cc(-c2ccc3c(c2)C(=O)CC(CO)(CO)O3)on1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.35
▸ CYP3A4 P08684 4/20 0.35
▸ CYP2C19 P33261 4/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ PKM P14618 1/20 0.35
▸ CYP2C9 P11712 3/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ DAGLB Q8NCG7 1/20 0.33
▸ DAGLA Q9Y4D2 1/20 0.33
▸ ACACB O00763 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25856883 0.92 S1PR1 (0.37) S1PR1CYP3A4CYP2C19CYP1A2HPGD
SCHEMBL23558442 0.84 S1PR1 (0.42) S1PR1CYP3A4CYP2C19CYP1A2HPGD
SCHEMBL23558568 0.79 HSD17B1 (0.46) CYP2C19CYP1A2HPGDCYP2C9NPC1
SCHEMBL23558481 0.78 RAB9A (0.42) CYP3A4CYP2C19CYP1A2HPGDCYP2C9
SCHEMBL23558589 0.78 NPC1 (0.33) CYP2C19CYP1A2HPGDCYP2C9NPC1
SCHEMBL30355606 0.76 S1PR1 (0.44) S1PR1HPGDNPC1TP53RAB9A
SCHEMBL23523749 0.76 S1PR1 (0.44) S1PR1HPGDNPC1TP53RAB9A
SCHEMBL23558433 0.76 HSD17B1 (0.51) HPGDNPC1TP53RAB9AALDH1A1
SCHEMBL23558330 0.75 RAB9A (0.40) CYP3A4CYP2C19CYP1A2HPGDCYP2C9
SCHEMBL23558404 0.74 ABCB1 (0.51) S1PR1HPGDNPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 S1PR1 1/4885CYP3A4 4104/4885CYP2C19 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback